Polymorphism of DC-SIGN (CD209) promoter in association with clinical symptoms of dengue fever.
Authors:
Oliveira, Layanna Freitas de Lima, Clayton Pereira Silva de Azevedo, Raimunda do Socorro Silva Mendonça, Dafne Silva Furtado de Rodrigues, Sueli Guerreiro Carvalho, Valéria Lima Pinto, Eliana Vieira Maia, Andreza Lopes Maia, Maria Helena Thomaz Vasconcelos, Janaina Mota Silva, Andrea Luciana Soares da Nunes, Márcio Roberto Teixeira Sena, Leonardo Vasconcelos, Pedro Fernando Santos, Eduardo José Melo dos
C-type lectin DC-SIGN receptor, encoded by CD209, plays a key role in the infection of dendritic cells by dengue virus (DENV). Because the -336A/G SNP (rs4804803) polymorphism in the promoter of CD209 modulates DC-SIGN expression, we investigated the putative association of this polymorphism with DENV infection and its pathogenesis. A control sample of 72 individuals, rigorously selected through a clinical investigation for absence of past dengue fever (DF) was compared to a sample of 168 patients (156 classical DF; 12 dengue hemorrhagic fever), all residents from Pará, Brazil. However, the prevalence of symptoms showed a trend higher in the AA genotype (Wilcoxon test; Z=2.02; p=0.04). Hence, our findings indicate that the G allele downregulates the spectrum of symptoms during the early acute phase of DENV infection, putatively decreasing the viremia, as suggested in the literature.